『GLP-1s on Trial! Ozempic, Metabolic Health & What You Really Should Know | LifeLONG』のカバーアート

GLP-1s on Trial! Ozempic, Metabolic Health & What You Really Should Know | LifeLONG

GLP-1s on Trial! Ozempic, Metabolic Health & What You Really Should Know | LifeLONG

無料で聴く

ポッドキャストの詳細を見る

概要

Want to join the show live and just hang out with Ethan and Co.?

Zoom isn’t just Q&A. It’s your all-access pass to LifeLONG: see some pre-show prep, stick around after we stop recording, and connect with the crew and other viewers. Get your personalized link here:

👉 https://us06web.zoom.us/meeting/register/jrw2LEWiSwy2fXG9ytocNA


Dave Knapp, founder of On The Pen, joins Ethan Suplee on LifeLONG for a wide-ranging conversation about the latest developments in GLP-1 medications, metabolic health, Type 2 diabetes, and obesity treatment. https://www.onthepen.com/about

Knapp has become one of the most trusted independent voices covering this fast-moving space, blending research, patient experience, and straight-talk analysis to help people understand how drugs like Ozempic, Wegovy, and Mounjaro actually work. From the surprising origin story of GLP-1 in Gila monster venom to today’s blockbuster prescriptions and new therapies on the horizon, we break down what’s real, what’s hype, and what these medications mean for long-term health.

Timing felt right. It’s the Monday after the Super Bowl. The snacks are gone, the leftovers are questionable, and half the country is quietly promising to “get it together.” Perfect moment to talk metabolism, habits, and what sustainable change actually looks like.

We cover the newest GLP-1 headlines, how these drugs affect appetite and blood sugar, common misconceptions, and how to think about obesity as a chronic, relapsing condition rather than a willpower problem.

Watch live on YouTube — or register above to come backstage, participate, and ask questions in real time. Subscribe for more conversations on strength, longevity, and lifelong health.


(00:00) Intro: The Super Bowl Hangover

(00:45) Novo Nordisk Sues Hims: The First Patent Lawsuit

(05:03) Did Hims Want This Fight? FDA Defiance

(09:27) The Marketing Problem: Being "First to Market"

(13:00) "Project Trump," Price Wars, and the FDA Crackdown

(17:05) The Science: Why Compounding Pills is Risky

(20:57) The Debate: Pharma R&D Costs vs. Patient Access

(26:08) Super Bowl Ads: Serena Williams & Obesity Stigma

(31:02) Why Insurance Companies Deny Coverage

(37:50) Q&A: Integrating Mental Health with GLP-1s

(42:36) Q&A: What If the Meds Don't Work? (Non-Responders)

(46:49) Q&A: Managing Stress & Diabetes (Trulicity to Mounjaro)

(49:55) Q&A: De-Moralizing Meds—They Are Just Tools

(56:08) Lightning Round with Dave Knapp

(58:38) Daily Nudge: Bad Bunny & Outro

Want to be on a future episode? Register here to join the conversation: 2way.tv/ethansuplee

Don't forget to subscribe to the YouTube for clips, full episodes, and more!

If you have any inspirational quotes to share, post them to Ethan's subreddit, r/EthanSupleeLifeLONG. It’s also a great place to discuss episodes, post about your successes, and embrace the community.

Lastly, you can send video questions to ethansupleeshow@2way.tv and we will play them on the show.

Hosted on Acast. See acast.com/privacy for more information.

まだレビューはありません